|
MSH6 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.800000E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.573160E-04 |
| Normal-vs-Stage2 |
2.873600E-01 |
| Normal-vs-Stage3 |
2.457600E-01 |
| Normal-vs-Stage4 |
7.050600E-01 |
| Stage1-vs-Stage2 |
3.127800E-01 |
| Stage1-vs-Stage3 |
1.794240E-02 |
| Stage1-vs-Stage4 |
1.780780E-01 |
| Stage2-vs-Stage3 |
1.041430E-01 |
| Stage2-vs-Stage4 |
3.304200E-01 |
| Stage3-vs-Stage4 |
6.892400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.297900E-02 |
| Normal-vs-AfricanAmerican |
1.787210E-01 |
| Normal-vs-Asian |
9.432400E-01 |
| Caucasian-vs-AfricanAmerican |
7.142800E-01 |
| Caucasian-vs-Asian |
5.240800E-01 |
| AfricanAmerican-vs-Asian |
5.794400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.05339999999055E-05 |
| Normal-vs-Female |
1.470170E-02 |
| Male-vs-Female |
4.0445000004663E-07 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.623800E-01 |
| Normal-vs-Extreme_Weight |
1.52766999998999E-05 |
| Normal-vs-Obese |
7.792200E-01 |
| Normal-vs-Extreme_Obese |
1.356040E-04 |
| Normal_Weight-vs-Extreme_Weight |
4.828100E-02 |
| Normal_Weight-vs-Obese |
2.970000E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.542200E-02 |
| Extreme_Weight-vs-Obese |
4.463700E-03 |
| Extreme_Weight-vs-Extreme_Obese |
3.765400E-01 |
| Obese-vs-Extreme_Obese |
4.001200E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.228100E-02 |
| Normal-vs-Age(41-60Yrs) |
2.035200E-01 |
| Normal-vs-Age(61-80Yrs) |
2.824600E-04 |
| Normal-vs-Age(81-100Yrs) |
2.475500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.961800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.012100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.430070E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.781900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.747200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.780800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.6753000000005E-05 |
| Normal-VS-Type2 PRCC |
1.497920E-03 |
| Normal-VS-KIRP CIMP |
1.797010E-03 |
| Normal-VS-Unclassified PRCC |
8.895800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.773000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.017400E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
4.858000E-02 |
| Type2 PRCC-VS-KIRP CIMP |
7.592600E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
7.340300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.615520E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.775300E-04 |
| Normal-vs-N1 |
1.603950E-02 |
| Normal-vs-N2 |
2.232800E-01 |
| N0-vs-N1 |
8.969800E-04 |
| N0-vs-N2 |
2.320700E-03 |
| N1-vs-N2 |
7.100200E-01 |
|
|
